← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 12, 2021Last known activity
Apr 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (7)
- NCT06350981Lead sponsorPhase 2/Phase 3Apr 30, 2024
- NCT05934500Lead sponsorEarly Phase 1Oct 15, 2023
- NCT05906433Lead sponsorPhase 1Jun 1, 2023
- NCT05240755Lead sponsorEarly Phase 1Oct 1, 2022
- NCT05240755Reponsible party - principal investigatorEarly Phase 1Oct 1, 2022
- NCT04874870Reponsible party - principal investigatorPhase 3Jul 12, 2021
- NCT04874870Lead sponsorPhase 3Jul 12, 2021
Details
- Last known activity
- Apr 30, 2024